Nimotuzumab

Nimotuzumab (h-R3, BIOMAb EGFR, Biocon, India; TheraCIM, CIMYM Biosciences, Canada; Theraloc, Oncoscience, Europe, CIMAher, Center of Molecular Immunology, Havana, Cuba) is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck, and was undergoing several clinical trials.

单词	Nimotuzumab
释义	Nimotuzumab 英语百科 Nimotuzumab Nimotuzumab (h-R3, BIOMAb EGFR, Biocon, India; TheraCIM, CIMYM Biosciences, Canada; Theraloc, Oncoscience, Europe, CIMAher, Center of Molecular Immunology, Havana, Cuba) is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck, and was undergoing several clinical trials.
随便看	UGK UGL UGLE Uglegorsk Uglegorskiy Rayon Uglekamensk uglesome Uglich Uglichskiy Rayon ugliest uglification uglify uglifier uglifies Ugli fruit uglifruit ugli fruits uglily ugliness Ugli Ugljan Ugljan, Otok Uglovka Uglovoye Uglovskiy Rayon